Company intelligence / Profile preview

Palmetto Pharmaceuticals

Greenville, South Carolina, United States

Ownership: Private
Development stage: Other

Overview

Palmetto Pharmaceuticals commercialized generic pharmaceuticals, notably naproxen oral suspension, for pain and inflammation. No proprietary drugs or clinical-stage assets identified; company specialized in licensed generic formulations with strong U.S. distribution. The company was a privately held, specialty generic pharma firm focused on affordable medicines before acquisition.

Therapeutic areas: ImmunologyNeurologyOther
Modalities: Small molecule
Industry: Biotech

Drug pipeline

1 asset

aminoethyl nitrate

Unknown

Partnerships

Rosemont Pharmaceuticals (acquirer/parent)possible wholesaler distribution partnerships pre-acquisition

Beyond the preview

Go deeper on Palmetto Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Palmetto Pharmaceuticals.

Explore the full profile